CCR5 and neoplasm: These results support the notion that CCR1 and CCR5 silencing modulates tumor driven differentiation of myeloid precursors by inhibiting MDSC polarization and increasing the number of myeloid cells that induce tumor death by a yet undisclosed mechanism.